Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Cleerly Launches with $43M Series B

2021-06-21
NEW YORK, NY, Cleerly launched with $43 million in Series B funding led by Vensana Capital.
Cleerly launched with $43 million in Series B funding and unveiled its digital care pathway solution for heart attack prevention.

The financing, which was led by Vensana Capital with participation from LRVHealth, New Leaf Venture Partners, DigiTx Partners, the American College of Cardiology, Cigna Ventures, and existing investors, brings Cleerly's total funding to $54 million.

Cleerly enables comprehensive phenotyping of coronary artery disease, as determined from advanced non-invasive CT imaging. Cleerly's digital care pathway leverages non-invasive coronary computed tomography (CT) angiography to perform comprehensive coronary artery phenotyping through AI-enabled and FDA-cleared solutions. This technology is based on millions of annotated lab images used to build more than two dozen proprietary algorithms capable of quantifying and characterizing the presence, extent, severity and type of coronary artery disease and other cardiovascular disorders.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors